VVOS — Vivos Therapeutics Inc · rev $10.3M

Vivos Therapeutics Inc (VVOS) is a medical devices company listed on NASDAQ.

Latest reported VVOS revenue for 2026-06-30 was $10.3M. Net income was -$13.2M. VVOS currently screens at market cap $7.1M.

Use this VVOS page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the VVOS quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the VVOS SEC filings page. Lician reads the product cache first so this HTML stays unique to Vivos Therapeutics Inc even when a live quote feed is slow.

Vivos Therapeutics Inc latest statements (FY2025)

Latest cached year on this hub. Full VVOS income, balance, and cash tables.

  • Revenue$17.4M
  • Net Income-$21.2M
  • Total Assets$25.2M
  • Total Debt$2.9M
  • Free Cash Flow-$17.6M

VVOS recent filings